Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

The Role of Otolaryngologists in Eradicating Human Papillomavirus.

Laitman BM, Ronner L, Genden E.

JAMA Otolaryngol Head Neck Surg. 2018 Dec 1;144(12):1186. doi: 10.1001/jamaoto.2018.2444. No abstract available.

PMID:
30286240
2.

Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model.

League-Pascual JC, Lester-McCully CM, Shandilya S, Ronner L, Rodgers L, Cruz R, Peer CJ, Figg WD, Warren KE.

J Neurooncol. 2017 May;132(3):401-407. doi: 10.1007/s11060-017-2388-x. Epub 2017 Mar 13.

PMID:
28290002
3.

Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.

Marron TU, Ronner L, Martin PE, Flowers CR, Brody JD.

Immunotherapy. 2016 Nov;8(11):1335-1346. Review.

PMID:
27993085
4.

CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer.

Higuchi T, Flies DB, Marjon NA, Mantia-Smaldone G, Ronner L, Gimotty PA, Adams SF.

Cancer Immunol Res. 2015 Nov;3(11):1257-68. doi: 10.1158/2326-6066.CIR-15-0044. Epub 2015 Jul 2.

5.

The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1--deficient ovarian tumors and can be exploited to improve treatment response in a mouse model.

Mantia-Smaldone G, Ronner L, Blair A, Gamerman V, Morse C, Orsulic S, Rubin S, Gimotty P, Adams S.

Gynecol Oncol. 2014 Jun;133(3):584-90. doi: 10.1016/j.ygyno.2014.03.565. Epub 2014 Mar 27.

PMID:
24680909

Supplemental Content

Loading ...
Support Center